Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Apr 2022 for Accelerate Diagnostics, Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ron Price: trading record in brief
Ron Price, listed as senior executive, appears in our data through filings on Accelerate Diagnostics, Inc shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 12 May 2021 and the latest from 21 April 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 25 April 2022 with an option exercise in Accelerate Diagnostics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ron Price
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2 of 2 declarations
